Heart failure: Pilot transcriptomic analysis of cardiac tissue by RNA-sequencing

Autor: Schiano C 1, Costa V 2, Aprile M 2, Grimaldi V 3, Maiello C 4, Esposito R 2, Soricelli A 1, 5, Colantuoni V 6, Donatelli F 7, Ciccodicola A 2, Napoli C 1, 3
Přispěvatelé: Schiano, Concetta, Costa, Valerio, Aprile, Marianna, Grimaldi, Vincenzo, Maiello, Ciro, Esposito, Roberta, Soricelli, Andrea, Colantuoni, Vittorio, Donatelli, Francesco, Ciccodicola, Alfredo, Napoli, Claudio
Jazyk: angličtina
Rok vydání: 2017
Předmět:
Male
0301 basic medicine
medicine.medical_specialty
Pathology
Population
RNA-sequencing
Pilot Projects
Heart failure
NoncodingRNA
Disease
Bioinformatics
Ventricular Function
Left

Transcriptome
Ventricular Dysfunction
Left

03 medical and health sciences
Internal medicine
medicine
Humans
Gene Regulatory Networks
RNA
Messenger

Mediator complex
Family history
education
Gene
Aged
education.field_of_study
Sequence Analysis
RNA

business.industry
Gene Expression Profiling
Myocardium
Cardiovascular disease
Cardiology and Cardiovascular Medicine
Restrictive cardiomyopathy
Computational Biology
Dilated cardiomyopathy
General Medicine
Middle Aged
medicine.disease
ncRNA
030104 developmental biology
Case-Control Studies
Cardiology
Female
RNA
Long Noncoding

cardiovascular disease
heart failure
mediator complex
business
Zdroj: Cardiology Journal (Online) 24 (2017): 539–553. doi:10.5603/CJ.a2017.0052
info:cnr-pdr/source/autori:Schiano C 1, Costa V 2, Aprile M 2, Grimaldi V 3, Maiello C 4, Esposito R 2, Soricelli A 1, 5, Colantuoni V 6, Donatelli F 7, Ciccodicola A 2, 5, Napoli C 1, 3/titolo:Heart failure: Pilot transcriptomic analysis of cardiac tissue by RNA-sequencing/doi:10.5603%2FCJ.a2017.0052/rivista:Cardiology Journal (Online)/anno:2017/pagina_da:539/pagina_a:553/intervallo_pagine:539–553/volume:24
DOI: 10.5603/CJ.a2017.0052
Popis: Background: Despite left ventricular (LV) dysfunction contributing to mortality in chronic heart failure (HF), the molecular mechanisms of LV failure continues to remain poorly understood and myocardial biomarkers have yet to be identified. The aim of this pilot study was to investigate specific transcriptome changes occurring in cardiac tissues of patients with HF compared to healthy condition patients to improve diagnosis and possible treatment of affected subjects. Methods: Unlike other studies, only dilated cardiomyopathy (DCM) (n = 2) and restrictive cardiomyopathy (RCM) (n = 2) patients who did not report family history of the disease were selected with the aim of obtaining a homogeneous population for the study. The transcriptome of all patients were studied by RNA-sequencing (RNA-Seq) and the read counts were adequately filtered and normalized using a recently developed user-friendly tool for RNA-Seq data analysis, based on a new graphical user interface (RNA-SeqGUI). Results: By using this approach in a pairwise comparison with healthy donors, we were able to identify DCM- and RCM-specific expression signatures for protein-coding genes as well as for long noncoding RNAs (lncRNAs). Differential expression of 5 genes encoding different members of the mediator complex was disclosed in this analysis. Interestingly, a significant alteration was found for genes which had never been associated with HF until now, and 27 lncRNA/mRNA pairs that were significantly altered in HF patients. Conclusions: The present findings revealed specific expression pattern of both protein-coding and lncRNAs in HF patients, confirming that new LV myocardial biomarkers could be reliably identified using Next-Generation Sequencing-based approaches.
Databáze: OpenAIRE